查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1533986

植入式心臟整流去颤器(ICD) 的全球市场

Implantable Cardioverter Defibrillators (ICD)
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 250 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球植入式心臟整流去颤器(ICD) 市场将达到 117 亿美元

预计 2023 年全球植入式心臟整流去颤器(ICD) 市场规模为 103 亿美元，预计到 2030 年将达到 117 亿美元，2023-2030 年分析期间复合年增长率为 1.9%。经静脉 ICD 是本报告分析的细分市场之一，预计复合年增长率为 1.7%，到分析期结束时将达到 110 亿美元。在分析期间，皮下强迫症部分的复合年增长率估计为 5.2%。

美国市场预估28亿美元，中国预期复合年增长率3.9%

预计 2023 年美国植入式心臟整流去颤器(ICD) 市场规模将达 28 亿美元。中国作为全球第二大经济体，预计2030年市场规模将达到23亿美元，2023年至2030年的分析期间复合年增长率为3.9%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 0.4% 和 1.3%。在欧洲，德国的复合年增长率预计为 0.8%。

全球植入式心臟整流去颤器(ICD) 市场 - 主要趋势与驱动因素总结

植入式心臟整流去颤器(ICD) 是一种先进的医疗设备，旨在监测心律并提供挽救生命的电击以纠正潜在致命的心律不整。该装置被植入因心室颤动或心室心搏过速而导致心臟麻痹的高风险患者。 ICD 持续监测心臟的电活动，并在侦测到异常节律时自动发出电击，从而防止心臟猝死。现代 ICD 还具有起搏功能，可以帮助管理不太严重的心律不整。 ICD 技术的进步显着提高了严重心臟疾病患者的生存率和生活质量，使该设备成为心臟病管理的基石。

技术进步是 ICD 发展的关键驱动力，使设备变得更小、更可靠，并实现更先进的诊断和治疗性介入。无引线 ICD 等创新消除了对经静脉引线的需求，正在减少与引线失效和感染相关的併发症。此外，远端监控功能的整合使医疗保健提供者能够即时追踪 ICD 性能和患者心律，从而促进及时的医疗干预。电池技术的进步延长了 ICD 的使用寿命，减少了频繁更换的需要和相关的手术风险。此外，先进演算法的实施提高了心律不整检测和治疗的准确性，最大限度地减少不适当的电击并改善患者的治疗结果。

ICD 市场的成长受到多种因素的推动。心血管疾病的盛行率不断上升，特别是人口老化，增加了对有效心律不整管理解决方案的需求。 MRI 安全 ICD 的开发和皮下 ICD 的出现等创新正在透过使这些设备适应更广泛的患者来扩大潜在市场。提高患者和医疗保健专业人员对 ICD 益处的认识和教育也推动了市场成长。此外，许多地区的政府支持政策和报销框架使患者更容易获得 ICD。医疗设备製造商和医疗保健提供者之间的策略联盟和合作也正在促进下一代 ICD 的开发和采用。此外，个人化医疗和针对患者的治疗计划的趋势正在提高ICD治疗的客製化和精确度，使其更加有效和有吸引力。这些因素结合在一起，使植入式心臟整流去颤器市场充满活力并迅速扩张。

受访企业范例（共86家）

  • Abbott Laboratories
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • EBR Systems,Inc.
  • Element Science, Inc.
  • MEDICO SRL
  • Medtronic Inc
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Purple MicroPort Cardiovascular Pvt Ltd
  • ZOLL Medical Corporation;

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP26848

Global Implantable Cardioverter Defibrillators (ICD) Market to Reach US$11.7 Billion by 2030

The global market for Implantable Cardioverter Defibrillators (ICD) estimated at US$10.3 Billion in the year 2023, is expected to reach US$11.7 Billion by 2030, growing at a CAGR of 1.9% over the analysis period 2023-2030. Transvenous ICD, one of the segments analyzed in the report, is expected to record a 1.7% CAGR and reach US$11.0 Billion by the end of the analysis period. Growth in the Subcutaneous OCD segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 3.9% CAGR

The Implantable Cardioverter Defibrillators (ICD) market in the U.S. is estimated at US$2.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 3.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.4% and 1.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 0.8% CAGR.

Global Implantable Cardioverter Defibrillators (ICD) Market - Key Trends and Drivers Summarized

Implantable Cardioverter Defibrillators (ICDs) are advanced medical devices designed to monitor heart rhythms and deliver life-saving electrical shocks to correct potentially fatal arrhythmias. These devices are implanted in patients who are at high risk of sudden cardiac arrest due to ventricular fibrillation or ventricular tachycardia. ICDs continuously monitor the heart's electrical activity and automatically deliver shocks when abnormal rhythms are detected, thereby preventing sudden cardiac death. Modern ICDs also offer pacing capabilities, which can help manage less severe rhythm disturbances. The evolution of ICD technology has significantly improved survival rates and quality of life for patients with serious cardiac conditions, making these devices a cornerstone in the management of heart disease.

Technological advancements have been a key driver in the evolution of ICDs, leading to devices that are smaller, more reliable, and capable of more sophisticated diagnostics and therapeutic interventions. Innovations such as leadless ICDs, which eliminate the need for transvenous leads, have reduced complications associated with lead failures and infections. Additionally, the integration of remote monitoring capabilities allows healthcare providers to track the performance of ICDs and the heart rhythms of patients in real-time, facilitating timely medical interventions. Advancements in battery technology have extended the lifespan of ICDs, reducing the need for frequent replacements and the associated surgical risks. Furthermore, the incorporation of advanced algorithms has enhanced the precision of arrhythmia detection and therapy, minimizing inappropriate shocks and improving patient outcomes.

The growth in the ICD market is driven by several factors. The rising prevalence of cardiovascular diseases, particularly in aging populations, has increased the demand for effective arrhythmia management solutions. Technological innovations, including the development of MRI-safe ICDs and the advent of subcutaneous ICDs, have expanded the addressable market by making these devices suitable for a broader range of patients. Increasing awareness and education about the benefits of ICDs among patients and healthcare providers are also propelling market growth. Additionally, supportive government policies and reimbursement frameworks in many regions are making ICDs more accessible to patients. Strategic collaborations and partnerships between medical device companies and healthcare providers are fostering the development and adoption of next-generation ICD technologies. Furthermore, the trend towards personalized medicine and patient-specific treatment plans is driving the customization and precision of ICD therapies, enhancing their effectiveness and appeal. Collectively, these factors are contributing to a dynamic and rapidly expanding market for implantable cardioverter defibrillators.

Select Competitors (Total 86 Featured) -

  • Abbott Laboratories
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • EBR Systems,Inc.
  • Element Science, Inc.
  • MEDICO S.R.L.
  • Medtronic Inc
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Purple MicroPort Cardiovascular Pvt Ltd
  • ZOLL Medical Corporation;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Implantable Cardioverter Defibrillators (ICD) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases Spurs Demand for ICDs
    • Technological Innovations Propel Growth in ICD Adoption
    • Development of MRI-Safe ICDs Expands Addressable Market Opportunity
    • Advancements in Leadless ICD Technology Strengthen Business Case for Newer Devices
    • Integration of Remote Monitoring Capabilities Drives Market Expansion
    • Trend towards Personalized Medicine Drives Adoption of Tailored ICD Therapies
    • Extended Battery Life of ICDs Sustains Growth in Market Demand
    • Rising Geriatric Population Throws the Spotlight on Need for Cardiac Care Solutions
    • Real-Time Data and Advanced Algorithms Enhance Precision and Minimize Inappropriate Shocks
    • Emergence of Subcutaneous ICDs Generates New Market Opportunities
    • Improved Patient Outcomes Strengthen Business Case for ICD Use
    • Here's the Story: Reducing Surgical Risks with Innovative ICD Designs
    • Increasing Healthcare Expenditure in Emerging Markets Drives Adoption
    • Growing Trend of Outpatient Cardiac Monitoring Spurs Demand for Remote ICD Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Implantable Cardioverter Defibrillators (ICD) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Transvenous ICD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Transvenous ICD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Transvenous ICD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Subcutaneous OCD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Subcutaneous OCD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Subcutaneous OCD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Single-Chamber ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Single-Chamber ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Single-Chamber ICDs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Dual-Chamber ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Dual-Chamber ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Dual-Chamber ICDs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Biventricular Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Biventricular Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Biventricular Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hospital End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Implantable Cardioverter Defibrillators (ICD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Implantable Cardioverter Defibrillators (ICD) by Product Type - Transvenous ICD and Subcutaneous OCD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Product Type - Percentage Breakdown of Value Sales for Transvenous ICD and Subcutaneous OCD for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Implantable Cardioverter Defibrillators (ICD) by Type - Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by Type - Percentage Breakdown of Value Sales for Single-Chamber ICDs, Dual-Chamber ICDs and Biventricular Devices for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Implantable Cardioverter Defibrillators (ICD) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Implantable Cardioverter Defibrillators (ICD) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION